Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Ko-Med Centra Kliniczne Sp. z o.o.

Research site

Poland Ul. 11 Listopada 78, 28-200 Staszow, Poland

  • Escherichia infection · Influenza · Respiratory syncytial virus infection
  • Adult patients

About Specializations

Ko-Med Centra Kliniczne Sp. z o.o. in Staszow, Poland specialises in clinical trials of conditions such as Escherichia infection, Influenza, Respiratory syncytial virus infection, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases and Bacterial Infections and Mycoses

At Ko-Med Centra Kliniczne Sp. z o.o. in Staszow, clinical research in General Medicine focuses on common infectious threats in older adults, especially influenza, RSV-associated disease, and prevention of invasive disease caused by Escherichia coli. These studies are designed to assess how well new and existing vaccines protect against infection and support stronger immune responses.

  • Evaluating vaccine effectiveness for influenza in adults 65 and older
  • Studying protection against invasive extraintestinal pathogenic Escherichia coli disease
  • Assessing immune response and protection against RSV in older adults

The site’s trials mainly compare vaccine performance, safety, and immune response to help improve prevention of respiratory and bacterial infections in aging populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. 11 Listopada 7828-200 StaszowPoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
3

More sites in StaszowPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Respiratory syncytial virus infection

Not recruiting

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:GlaxoSmithKline Biologicals

Escherichia infection

Not recruiting

Study on the Safety and Immune Response of JNJ-78901563 and High-dose Influenza Vaccine in Preventing E. coli Infections in Adults Aged 65 and Older

Registered drug
Countries:PolandPoland
  • Participants:65+ years · Healthy volunteers
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Influenza

Not recruiting

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo
Countries:PolandPoland
  • Participants:65+ years · Healthy volunteers
  • Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
  • Sponsor:Seqirus UK Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.